Levels of Apolipoprotein A1, B100 and Lipoprotein (a) in Controlled and Uncontrolled Diabetic Patients and in Non-Diabetic Healthy People
| Autor: | Vishwal Indravadan Patel, Kinjal Prahaladbhai Patel, Kaushik Salubhai Chaudhari, Haridas Neelakandan Nilayangode, Mayur Goradhanbhai Makadia, Aashna Darshanbhai Shah |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Apolipoprotein B cardiovascular disorders hba1c Clinical Biochemistry lcsh:Medicine 03 medical and health sciences Diabetes mellitus Internal medicine medicine Biochemistry Section Glycemic biology medicine.diagnostic_test business.industry lcsh:R General Medicine Lipoprotein(a) medicine.disease lipid profile 030104 developmental biology Endocrinology biology.protein Apolipoprotein A1 lipids (amino acids peptides and proteins) Lipid profile business Dyslipidemia Lipoprotein |
| Zdroj: | Journal of Clinical and Diagnostic Research, Vol 11, Iss 2, Pp BC01-BC05 (2017) |
| ISSN: | 2249-782X |
| Popis: | Introduction: Diabetes Mellitus (DM) is always a multifactorial metabolic disorder having a wide range of abnormalities in carbohydrate, lipid and protein metabolism. Dyslipidemia is a natural process of DM causing abnormal variations of different lipoproteins and it is one of the significant risk factors for Cardiovascular Disorder (CVD). There is a need to closely evaluate newer approaches in case of DM because even if dyslipidemia is treated, there is always a risk of CVDs in DM patients because of the hyperglycemia itself. So, lipid abnormalities should be assessed aggressively and treated as part of diabetes care. Apolipoprotein B100 (Apo B100), Apolipoprotein A1 (Apo A1) and Lipoprotein (a) {Lp(a)} are newer markers which are always welcome and necessary as many of the reported cases with normal conventional lipid profile have developed cardiac events. Aim: Study the correlation between glycemic control and the levels of Apo A1, Apo B100 and Lp(a). Materials and Methods : Total 56 patients of (DM) diagnosed on the basis of American Diabetic Association guidelines were recruited, out of which 28 were identified as uncontrolleddiabetic patients and remaining 28 as controlled-diabetics on the basis of Glycosylated HbA1c (HbA1c). The control group consisted of normal healthy 28 individuals. Apo B100, Apo A1 and Lp(a) along with traditional lipid profile, Fasting Blood Sugar (FBS) and HbA1c were estimated in all the subjects. Results: Apo B100/Apo A1 ratio and Lp(a) levels showed highly significant difference (p-value |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|